Series B Investment In Mfine - A Heath-Tech Startup

ND
Nishith Desai Associates

Contributor

Nishith Desai Associates logo
With offices in Asia-Pacific, Europe and the United States Nishith Desai Associates is the go-to firm for corporates looking to conduct business in India as well as for Indian companies looking to set up operations abroad; navigate the complex business regulations and grow.
SBI (through its investment vehicles in Japan and Singapore), Beenext, along with other investors led the Series B investment of approx. USD 17 million
India Food, Drugs, Healthcare, Life Sciences

DEAL BRIEF

SBI (through its investment vehicles in Japan and Singapore), Beenext, along with other investors led the Series B investment of approx. USD 17 million into NovoCura Tech Health Services Private Limited (doing business as 'mfine'), a health-tech startup based out of Bengaluru, India. Mfine was founded in 2017 by Ashutosh Lawania (co-founder of Myntra) and Prasad Kompalli (former chief business officer of Myntra).

SBI is an internet-based financial conglomerate from Japan and Beenext is a leading venture capital firm from Singapore. Press coverage, relating to the transaction, is available at the Hindu Business Line and Livemint.

OUR ROLE

We, at Nishith Desai Associates,acted as legal counsels to SBI and Beenext. We advised them on the legal, regulatory and strategic aspects of the transaction.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More